Literature DB >> 17342306

Co-expression of gastric and biliary phenotype in pyloric-gland type adenoma of the gallbladder: immunohistochemical analysis of mucin profile and CD10.

Shigenori Nagata1, Yoichi Ajioka, Ken Nishikura, Gen Watanabe, Takahiro Inoue, Koji Yamaguchi, Hidenobu Watanabe, Masao Tanaka, Masazumi Tsuneyoshi.   

Abstract

Pyloric-gland type adenoma of the gallbladder is formed by proliferation of glands resembling pyloric glands, morphologically. No previous report has described the cellular phenotype and differentiation of pyloric-gland type adenoma of the gallbladder, using CD10 as a marker of proper biliary phenotype. Immunostainings were performed for mucin markers such as MUC5AC, human gastric mucin (HGM) for gastric foveolar type epithelium, MUC6, M-GGMC-1 for pyloric-gland type and MUC2 for intestinal goblet-cell type, and for CD10 as a proper biliary type marker on 58 pyloric-gland type adenomas of the gallbladder, as well as for p53, Ki-67 and CDX2. The percentage (X) of reactive cells in relation to the total number of tumor cells was estimated semi-quantitatively, and divided into four categories: X=0% (negative), 0%<X<10%, 10%<or=X<30%, and X>or=30%. CDX2 expression was considered to be positive when the percentage of positively stained cells was >or=10%. Out of the 58 pyloric-gland type adenomas, >or=30% of adenoma cells were positive for MUC5AC in 22 (38%) tumors, HGM in 29 (50%), MUC6 in 58 (100%), M-GGMC-1 in 54 (93%), MUC2 in none (0%), and CD10 in 20 (34%). MUC6 (P<0.001) and M-GGMC-1 (P<0.001) mucins were detected more frequently in pyloric-gland type adenomas, and CD10 expression was significantly decreased, compared with normal gallbladder epithelium (P=0.006). P53 overexpression was not found in any of the 58 tumors, including two adenomas with carcinomatous foci. The mean number of Ki-67-positive cells was 10.3+/-5.8%. CDX2 expression was judged as negative in all 58 pyloric-gland type adenomas. In pyloric-gland type adenomas of the gallbladder, expression of pyloric-gland type mucins was observed with a high frequency, whereas intestinal goblet-cell mucins were rarely seen. In addition, co-expression of gastric foveolar type mucins and CD10 was also demonstrated. Pyloric-gland type adenomas of the gallbladder show a differentiation toward pyloric glands in terms of immunohistochemistry, as well as morphology, accompanied by co-expression of gastric foveolar and native biliary phenotypes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17342306

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  5 in total

1.  Aberrant expression of an "intestinal marker" Cdx2 in pyloric gland adenoma of the gallbladder.

Authors:  Yoji Wani; Kenji Notohara; Masayoshi Fujisawa
Journal:  Virchows Arch       Date:  2008-10-09       Impact factor: 4.064

Review 2.  Heterotopic gastric mucosa in the hilar bile duct mimicking hilar cholangiocarcinoma: report of a case.

Authors:  Saburo Fukuda; Syoichiro Mukai; Seiichi Shimizu; Masatoshi Kouchi; Seiji Fujisaki; Mamoru Takahashi; Hideto Sakimoto; Takaaki Eto; Makoto Takahashi; Toshihiro Nishida
Journal:  Surg Today       Date:  2012-06-17       Impact factor: 2.549

Review 3.  Pathology of gallbladder carcinoma: current understanding and new perspectives.

Authors:  Munita Meenu Bal; Mukta Ramadwar; Kedar Deodhar; Shailesh Shrikhande
Journal:  Pathol Oncol Res       Date:  2015-01-25       Impact factor: 3.201

4.  Pyloric gland adenoma of gallbladder-reports of two cases and a brief review of literature.

Authors:  Guang Yang; Haixia Qin; Anwar Raza; George W Saukel; Naveenraj Solomon; Marcos Michelotti; Ravi Raghavan
Journal:  J Gastrointest Oncol       Date:  2016-04

5.  Alterations in mucin expression in ovarian mucinous tumors: immunohistochemical analysis of MUC2, MUC5AC, MUC6, and CD10 expression.

Authors:  Kenichi Hirabayashi; Masanori Yasuda; Hiroshi Kajiwara; Johbu Itoh; Masaki Miyazawa; Takeshi Hirasawa; Toshinari Muramatsu; Masaru Murakami; Mikio Mikami; Robert Yoshiyuki Osamura
Journal:  Acta Histochem Cytochem       Date:  2008-04-26       Impact factor: 1.938

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.